{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T15:38:09Z","timestamp":1776872289582,"version":"3.51.2"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T00:00:00Z","timestamp":1740614400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T00:00:00Z","timestamp":1740614400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100018472","name":"Juhani Ahon L\u00e4\u00e4ketieteen Tutkimuss\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018472","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007634","name":"Ida Montinin S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007634","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008413","name":"Instrumentariumin Tiedes\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008413","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010711","name":"Sy\u00f6p\u00e4s\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007083","name":"Orionin Tutkimuss\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007083","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007417","name":"Paulon S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007417","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2021-02298"],"award-info":[{"award-number":["2021-02298"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2021-02298"],"award-info":[{"award-number":["2021-02298"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Research Council of Finland","doi-asserted-by":"publisher","award":["352814"],"award-info":[{"award-number":["352814"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004012","name":"Jane ja Aatos Erkon S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004012","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006306","name":"Sigrid Jus\u00e9liuksen S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","award":["230002"],"award-info":[{"award-number":["230002"]}],"id":[{"id":"10.13039\/501100006306","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["695727"],"award-info":[{"award-number":["695727"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"name":"iCAN Digital Precision Cancer Medicine Flagship","award":["320185"],"award-info":[{"award-number":["320185"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BJC Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>\n              <jats:italic>Fibroblast growth factor 1-4 (FGFR1-4)<\/jats:italic> are well-known oncogenic drivers in many cancer types. Here, we studied the role of FGFRs in uterine leiomyoma (UL) that is a benign neoplasm arising from the myometrium and the most common tumour in women. Although ULs can be classified to molecular subtypes based on genetic drivers, potential secondary drivers are not well characterised.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We performed mutation analysis of RNA-sequencing data of ULs, followed by screening of <jats:italic>FGFR<\/jats:italic> alterations in our Finnish (<jats:italic>n<\/jats:italic>\u2009=\u20092677) and Swedish (<jats:italic>n<\/jats:italic>\u2009=\u2009372) UL collections, utilising Sanger-, next-generation and Nanopore sequencing and SNP array data. The role of <jats:italic>FGFR<\/jats:italic> genes in UL predisposition was examined by GWAS.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>We identified FGFR activation in a subset of ULs on both genetic and epigenetic levels. In addition to single-nucleotide mutations in <jats:italic>FGFR1\/2<\/jats:italic>, we detected an <jats:italic>FGFR2-ERC1<\/jats:italic> fusion gene, <jats:italic>FGFR1<\/jats:italic> gains and hypomethylation of regulatory regions of <jats:italic>FGFR2\/3<\/jats:italic>. <jats:italic>FGFR<\/jats:italic> alterations were enriched in molecularly similar HMGA2, HMGA1 and PLAG1 UL subtypes. We also unveil a UL predisposing variant upstream of <jats:italic>FGFR4<\/jats:italic> associated with increased expression in both normal myometrium and ULs.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Our results establish the role of FGFR signalling in the genesis of UL.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1038\/s44276-025-00127-4","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T13:05:01Z","timestamp":1740747901000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Activation of FGFR genes by genetic and epigenetic alterations in uterine leiomyomas"],"prefix":"10.1038","volume":"3","author":[{"given":"Vilja","family":"Jokinen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aurora","family":"Taira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c5sa","family":"Kolterud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isa","family":"Ahlgren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimmo","family":"Palin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riku","family":"Katainen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maritta","family":"R\u00e4is\u00e4nen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eevi","family":"Kaasinen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sini","family":"Ilves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anniina","family":"Raitila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helena","family":"Kopp Kallner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"Siili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralf","family":"B\u00fctzow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oskari","family":"Heikinheimo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annukka","family":"Pasanen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Auli","family":"Karhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niko","family":"V\u00e4lim\u00e4ki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6839-4286","authenticated-orcid":false,"given":"Lauri A.","family":"Aaltonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,27]]},"reference":[{"key":"127_CR1","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1067\/mob.2003.99","volume":"188","author":"DD Baird","year":"2003","unstructured":"Baird DD, Dunson DB, Hill MC, Cousins D, Schectman JM. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol. 2003;188:100\u20137.","journal-title":"Am J Obstet Gynecol"},{"key":"127_CR2","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1111\/1471-0528.14640","volume":"124","author":"EA Stewart","year":"2017","unstructured":"Stewart EA, Cookson CL, Gandolfo RA, Schulze-Rath R. Epidemiology of uterine fibroids: a systematic review. BJOG. 2017;124:1501\u201312.","journal-title":"BJOG"},{"key":"127_CR3","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1055\/s-0037-1607264","volume":"35","author":"A Al-Hendy","year":"2017","unstructured":"Al-Hendy A, Myers ER, Stewart E. Uterine fibroids: burden and unmet medical need. Semin Reprod Med. 2017;35:473\u201380.","journal-title":"Semin Reprod Med"},{"key":"127_CR4","doi-asserted-by":"publisher","first-page":"211.e1","DOI":"10.1016\/j.ajog.2011.12.002","volume":"206","author":"ER Cardozo","year":"2012","unstructured":"Cardozo ER, Clark AD, Banks NK, Henne MB, Stegmann BJ, Segars JH. The estimated annual cost of uterine leiomyomata in the United States. Am J Obstet Gynecol. 2012;206:211.e1\u20139.","journal-title":"Am J Obstet Gynecol"},{"key":"127_CR5","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1126\/science.1208930","volume":"334","author":"N M\u00e4kinen","year":"2011","unstructured":"M\u00e4kinen N, Mehine M, Tolvanen J, Kaasinen E, Li Y, Lehtonen HJ, et al. MED12, the mediator complex subunit 12 gene, is mutated at high frequency in uterine leiomyomas. Science. 2011;334:252\u20135.","journal-title":"Science"},{"key":"127_CR6","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1073\/pnas.1518752113","volume":"113","author":"M Mehine","year":"2016","unstructured":"Mehine M, Kaasinen E, Heinonen HR, M\u00e4kinen N, K\u00e4mpj\u00e4rvi K, Sarvilinna N, et al. Integrated data analysis reveals uterine leiomyoma subtypes with distinct driver pathways and biomarkers. Proc Natl Acad Sci USA. 2016;113:1315\u201320.","journal-title":"Proc Natl Acad Sci USA"},{"key":"127_CR7","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/ng849","volume":"30","author":"IPM Tomlinson","year":"2002","unstructured":"Tomlinson IPM, Alam NA, Rowan AJ, Barclay E, Jaeger EEM, Kelsell D, et al. Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer. Nat Genet. 2002;30:406\u201310.","journal-title":"Nat Genet"},{"key":"127_CR8","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0002-9440(10)63091-X","volume":"164","author":"R Lehtonen","year":"2004","unstructured":"Lehtonen R, Kiuru M, Vanharanta S, Sj\u00f6berg J, Aaltonen L-M, Aittom\u00e4ki K, et al. Biallelic inactivation of fumarate hydratase (FH) occurs in nonsyndromic uterine leiomyomas but is rare in other tumors. Am J Pathol. 2004;164:17\u201322.","journal-title":"Am J Pathol"},{"key":"127_CR9","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/s41586-021-03747-1","volume":"596","author":"DG Berta","year":"2021","unstructured":"Berta DG, Kuisma H, V\u00e4lim\u00e4ki N, R\u00e4is\u00e4nen M, J\u00e4ntti M, Pasanen A, et al. Deficient H2A.Z deposition is associated with genesis of uterine leiomyoma. Nature. 2021;596:398\u2013403. https:\/\/doi.org\/10.1038\/s41586-021-03747-1","journal-title":"Nature"},{"key":"127_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41389-022-00425-3","volume":"11","author":"M Mehine","year":"2022","unstructured":"Mehine M, Ahvenainen T, Khamaiseh S, H\u00e4rk\u00f6nen J, Reinikka S, Heikkinen T, et al. A novel uterine leiomyoma subtype exhibits NRF2 activation and mutations in genes associated with neddylation of the Cullin 3-RING E3 ligase. Oncogenesis. 2022;11:52.","journal-title":"Oncogenesis"},{"key":"127_CR11","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/gcc.23088","volume":"62","author":"V Jokinen","year":"2023","unstructured":"Jokinen V, Mehine M, Reinikka S, Khamaiseh S, Ahvenainen T, \u00c4yr\u00e4v\u00e4inen A, et al. 3\u2019RNA and whole-genome sequencing of archival uterine leiomyomas reveal a tumor subtype with chromosomal rearrangements affecting either HMGA2, HMGA1, or PLAG1. Genes Chromosomes Cancer. 2023;62:27\u201338.","journal-title":"Genes Chromosomes Cancer"},{"key":"127_CR12","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.fertnstert.2014.06.050","volume":"102","author":"M Mehine","year":"2014","unstructured":"Mehine M, M\u00e4kinen N, Heinonen HR, Aaltonen LA, Vahteristo P. Genomics of uterine leiomyomas: Insights from high-throughput sequencing. Fertil Steril. 2014;102:621\u20139.","journal-title":"Fertil Steril"},{"key":"127_CR13","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1002\/med.21288","volume":"34","author":"M Katoh","year":"2014","unstructured":"Katoh M, Nakagama H. FGF receptors: cancer biology and therapeutics. Med Res Rev. 2014;34:280\u2013300.","journal-title":"Med Res Rev"},{"key":"127_CR14","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1158\/1078-0432.CCR-14-3212","volume":"22","author":"T Helsten","year":"2016","unstructured":"Helsten T, Elkin S, Arthur E, Tomson BN, Carter J, Kurzrock R. The FGFR landscape in cancer: analysis of 4853 tumors by next-generation sequencing. Clin Cancer Res. 2016;22:259\u201367.","journal-title":"Clin Cancer Res"},{"key":"127_CR15","doi-asserted-by":"publisher","first-page":"D941","DOI":"10.1093\/nar\/gky1015","volume":"47","author":"JG Tate","year":"2019","unstructured":"Tate JG, Bamford S, Jubb HC, Sondka Z, Beare DM, Bindal N, et al. COSMIC: the catalogue of somatic mutations in cancer. Nucleic Acids Res. 2019;47:D941\u2013D947.","journal-title":"Nucleic Acids Res"},{"key":"127_CR16","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1038\/s41416-020-01157-0","volume":"124","author":"MA Krook","year":"2021","unstructured":"Krook MA, Reeser JW, Ernst G, Barker H, Wilberding M, Li G, et al. Fibroblast growth factor receptors in cancer: genetic alterations, diagnostics, therapeutic targets and mechanisms of resistance. Br J Cancer. 2021;124:880\u201392.","journal-title":"Br J Cancer"},{"key":"127_CR17","first-page":"497","volume":"80","author":"X Wu","year":"2001","unstructured":"Wu X, Blanck A, Olovsson M, M\u00f6ller B, Lindblom B. Expression of basic fibroblast growth factor (bFGF), FGF receptor 1 and FGF receptor 2 in uterine leiomyomas and myometrium during the menstrual cycle, after menopause and GnRHa treatment. Acta Obstet Gynecol Scand. 2001;80:497\u2013504.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"127_CR18","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1093\/molehr\/3.8.685","volume":"3","author":"CA Anania","year":"1997","unstructured":"Anania CA, Stewart EA, Quade BJ, Hill JA, Nowak RA. Expression of the fibroblast growth factor receptor in women with leiomyomas and abnormal uterine bleeding. Mol Hum Reprod. 1997;3:685\u201391.","journal-title":"Mol Hum Reprod"},{"key":"127_CR19","doi-asserted-by":"publisher","first-page":"e57901","DOI":"10.1371\/journal.pone.0057901","volume":"8","author":"PD Cirilo","year":"2013","unstructured":"Cirilo PD, Marchi FA, Barros Filho Mde C, Rocha RM, Domingues MA, Jurisica I, et al. An integrative genomic and transcriptomic analysis reveals potential targets associated with cell proliferation in uterine leiomyomas. PLoS ONE. 2013;8:e57901.","journal-title":"PLoS ONE"},{"key":"127_CR20","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1056\/NEJMoa1302736","volume":"369","author":"M Mehine","year":"2013","unstructured":"Mehine M, Kaasinen E, M\u00e4kinen N, Katainen R, K\u00e4mpj\u00e4rvi K, Pitk\u00e4nen E, et al. Characterization of uterine leiomyomas by whole-genome sequencing. N Engl J Med. 2013;369:43\u201353.","journal-title":"N Engl J Med"},{"key":"127_CR21","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1002\/ijc.28410","volume":"134","author":"N M\u00e4kinen","year":"2014","unstructured":"M\u00e4kinen N, Vahteristo P, B\u00fctzow R, Sj\u00f6berg J, Aaltonen LA. Exomic landscape of MED12 mutation-negative and -positive uterine leiomyomas. Int J Cancer. 2014;134:1008\u201312.","journal-title":"Int J Cancer"},{"key":"127_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550.","journal-title":"Genome Biol"},{"key":"127_CR23","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43:e47.","journal-title":"Nucleic Acids Res"},{"key":"127_CR24","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29:15\u201321.","journal-title":"Bioinformatics"},{"key":"127_CR25","unstructured":"Van der Auwera GA, O\u2019Connor BD. Genomics in the cloud: using docker, GATK, and WDL in Terra, 1st ed. (O\u2019Reilly Media: Sebastopol, CA, USA, 2020)."},{"key":"127_CR26","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/s41586-022-04558-8","volume":"604","author":"J Morales","year":"2022","unstructured":"Morales J, Pujar S, Loveland JE, Astashyn A, Bennett R, Berry A, et al. A joint NCBI and EMBL-EBI transcript set for clinical genomics and research. Nature. 2022;604:310\u20135.","journal-title":"Nature"},{"key":"127_CR27","doi-asserted-by":"publisher","first-page":"2580","DOI":"10.1038\/s41596-018-0052-3","volume":"13","author":"R Katainen","year":"2018","unstructured":"Katainen R, Donner I, Cajuso T, Kaasinen E, Palin K, M\u00e4kinen V, et al. Discovery of potential causative mutations in human coding and noncoding genome with the interactive software BasePlayer. Nat Protoc. 2018;13:2580\u20132600.","journal-title":"Nat Protoc"},{"key":"127_CR28","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41586-023-06045-0","volume":"625","author":"S Chen","year":"2024","unstructured":"Chen S, Francioli LC, Goodrich JK, Collins RL, Kanai M, Wang Q, et al. A genomic mutational constraint map using variation in 76,156 human genomes. Nature. 2024;625:92\u2013100.","journal-title":"Nature"},{"key":"127_CR29","doi-asserted-by":"publisher","first-page":"e164","DOI":"10.1093\/nar\/gkq603","volume":"38","author":"K Wang","year":"2010","unstructured":"Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 2010;38:e164.","journal-title":"Nucleic Acids Res"},{"key":"127_CR30","doi-asserted-by":"publisher","first-page":"D418","DOI":"10.1093\/nar\/gkac993","volume":"51","author":"T Paysan-Lafosse","year":"2023","unstructured":"Paysan-Lafosse T, Blum M, Chuguransky S, Grego T, Pinto BL, Salazar GA, et al. InterPro in 2022. Nucleic Acids Res. 2023;51:D418\u2013D427.","journal-title":"Nucleic Acids Res"},{"key":"127_CR31","doi-asserted-by":"crossref","unstructured":"Nicorici D, \u015eatalan M, Edgren H, Kangaspeska S, Murum\u00e4gi A, Kallioniemi O, et al. FusionCatcher\u2014a tool for finding somatic fusion genes in paired-end RNA-sequencing data. bioRxiv. 2014; 011650.","DOI":"10.1101\/011650"},{"key":"127_CR32","doi-asserted-by":"crossref","unstructured":"Karolchik D, Hinrichs AS, Furey TS, Roskin KM, Sugnet CW, Haussler D, et al. The UCSC Table Browser data retrieval tool. Nucleic Acids Res. 2004;32:D493\u20136.","DOI":"10.1093\/nar\/gkh103"},{"key":"127_CR33","doi-asserted-by":"crossref","unstructured":"Wickham H. ggplot2: elegant graphics for data analysis. Springer Science & Business Media; 2009 https:\/\/play.google.com\/store\/books\/details?id=bes-AAAAQBAJ.","DOI":"10.1007\/978-0-387-98141-3"},{"key":"127_CR34","doi-asserted-by":"publisher","DOI":"10.1093\/gigascience\/giab008","volume":"10","author":"P Danecek","year":"2021","unstructured":"Danecek P, Bonfield JK, Liddle J, Marshall J, Ohan V, Pollard MO, et al. Twelve years of SAMtools and BCFtools. Gigascience. 2021;10:giab008. https:\/\/doi.org\/10.1093\/gigascience\/giab008","journal-title":"Gigascience"},{"key":"127_CR35","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1038\/s41576-023-00668-9","volume":"24","author":"K Minton","year":"2023","unstructured":"Minton K. Predicting variant pathogenicity with AlphaMissense. Nat Rev Genet. 2023;24:804.","journal-title":"Nat Rev Genet"},{"key":"127_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-020-02107-y","volume":"21","author":"T Jiang","year":"2020","unstructured":"Jiang T, Liu Y, Jiang Y, Li J, Gao Y, Cui Z, et al. Long-read-based human genomic structural variation detection with cuteSV. Genome Biol. 2020;21:189.","journal-title":"Genome Biol"},{"key":"127_CR37","doi-asserted-by":"crossref","unstructured":"Jiang T, Cao S, Liu Y, Liu S, Liu B, Wang G et al. Regenotyping structural variants through an accurate force-calling method. bioRxiv. 2023; 2022.08.29.505534.","DOI":"10.1101\/2022.08.29.505534"},{"key":"127_CR38","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1093\/bib\/bbs017","volume":"14","author":"H Thorvaldsd\u00f3ttir","year":"2013","unstructured":"Thorvaldsd\u00f3ttir H, Robinson JT, Mesirov JP. Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration. Brief Bioinform. 2013;14:178\u201392.","journal-title":"Brief Bioinform"},{"key":"127_CR39","doi-asserted-by":"publisher","first-page":"16910","DOI":"10.1073\/pnas.1009843107","volume":"107","author":"P Van Loo","year":"2010","unstructured":"Van Loo P, Nordgard SH, Lingj\u00e6rde OC, Russnes HG, Rye IH, Sun W, et al. Allele-specific copy number analysis of tumors. Proc Natl Acad Sci USA. 2010;107:16910\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"127_CR40","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","volume":"613","author":"MI Kurki","year":"2023","unstructured":"Kurki MI, Karjalainen J, Palta P, Sipil\u00e4 TP, Kristiansson K, Donner KM, et al. FinnGen provides genetic insights from a well-phenotyped isolated population. Nature. 2023;613:508\u201318.","journal-title":"Nature"},{"key":"127_CR41","doi-asserted-by":"publisher","first-page":"e37110","DOI":"10.7554\/eLife.37110","volume":"7","author":"N V\u00e4lim\u00e4ki","year":"2018","unstructured":"V\u00e4lim\u00e4ki N, Kuisma H, Pasanen A, Heikinheimo O, Sj\u00f6berg J, B\u00fctzow R, et al. Genetic predisposition to uterine leiomyoma is determined by loci for genitourinary development and genome stability. Elife. 2018;7:e37110 https:\/\/doi.org\/10.7554\/eLife.37110","journal-title":"Elife"},{"key":"127_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05428-6","volume":"9","author":"T Rafnar","year":"2018","unstructured":"Rafnar T, Gunnarsson B, Stefansson OA, Sulem P, Ingason A, Frigge ML, et al. Variants associating with uterine leiomyoma highlight genetic background shared by various cancers and hormone-related traits. Nat Commun. 2018;9:3636.","journal-title":"Nat Commun"},{"key":"127_CR43","doi-asserted-by":"publisher","first-page":"651","DOI":"10.2147\/OTT.S364566","volume":"15","author":"C Hong","year":"2022","unstructured":"Hong C, Wei J, Zhou T, Wang X, Cai J. FGFR2-ERC1: a subtype of FGFR2 oncogenic fusion variant in lung adenocarcinoma and the response to anlotinib. Onco Targets Ther. 2022;15:651\u20137.","journal-title":"Onco Targets Ther"},{"key":"127_CR44","doi-asserted-by":"publisher","first-page":"2874","DOI":"10.21037\/gs-21-469","volume":"10","author":"J Ma","year":"2021","unstructured":"Ma J, Wang B, Meng E, Meng X. Case report: identification of ERC1-RET fusion in a patient with pancreatic ductal adenocarcinoma. Gland Surg. 2021;10:2874\u20139.","journal-title":"Gland Surg"},{"key":"127_CR45","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1210\/clinem\/dgaa913","volume":"106","author":"Y Liu","year":"2021","unstructured":"Liu Y, Wu S, Zhou L, Guo Y, Zeng X. Pitfalls in RET fusion detection using break-apart FISH probes in papillary thyroid carcinoma. J Clin Endocrinol Metab. 2021;106:1129\u201338.","journal-title":"J Clin Endocrinol Metab"},{"key":"127_CR46","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1111\/cas.15181","volume":"113","author":"M Shi","year":"2022","unstructured":"Shi M, Wang W, Zhang J, Li B, Lv D, Wang D, et al. Identification of RET fusions in a Chinese multicancer retrospective analysis by next-generation sequencing. Cancer Sci. 2022;113:308\u201318.","journal-title":"Cancer Sci"},{"key":"127_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.anndiagpath.2021.151800","volume":"54","author":"T Chen","year":"2021","unstructured":"Chen T, Wang Y, Goetz L, Corey Z, Dougher MC, Smith JD, et al. Novel fusion sarcomas including targetable NTRK and ALK. Ann Diagn Pathol. 2021;54:151800.","journal-title":"Ann Diagn Pathol"},{"key":"127_CR48","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1158\/1535-7163.MCT-19-0105","volume":"18","author":"M Cou\u00ebtoux du Tertre","year":"2019","unstructured":"Cou\u00ebtoux du Tertre M, Marques M, Tremblay L, Bouchard N, Diaconescu R, Blais N, et al. Analysis of the genomic landscape in ALK+ NSCLC patients identifies novel aberrations associated with clinical outcomes. Mol Cancer Ther. 2019;18:1628\u201336.","journal-title":"Mol Cancer Ther"},{"key":"127_CR49","doi-asserted-by":"publisher","first-page":"170258","DOI":"10.1098\/rsob.170258","volume":"8","author":"RG Held","year":"2018","unstructured":"Held RG, Kaeser PS. ELKS active zone proteins as multitasking scaffolds for secretion. Open Biol. 2018;8:170258 https:\/\/doi.org\/10.1098\/rsob.170258","journal-title":"Open Biol"},{"key":"127_CR50","first-page":"3862","volume":"127","author":"V Astro","year":"2014","unstructured":"Astro V, Chiaretti S, Magistrati E, Fivaz M, de Curtis I. Liprin-\u03b11, ERC1 and LL5 define polarized and dynamic structures that are implicated in cell migration. J Cell Sci. 2014;127:3862\u201376.","journal-title":"J Cell Sci"},{"key":"127_CR51","doi-asserted-by":"publisher","first-page":"S81","DOI":"10.1016\/j.molmet.2019.06.017","volume":"27S","author":"M Ohara-Imaizumi","year":"2019","unstructured":"Ohara-Imaizumi M, Aoyagi K, Ohtsuka T. Role of the active zone protein, ELKS, in insulin secretion from pancreatic \u03b2-cells. Mol Metab. 2019;27S:S81\u2013S91.","journal-title":"Mol Metab"},{"key":"127_CR52","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13072-018-0205-1","volume":"11","author":"D Anastasiadi","year":"2018","unstructured":"Anastasiadi D, Esteve-Codina A, Piferrer F. Consistent inverse correlation between DNA methylation of the first intron and gene expression across tissues and species. Epigenetics Chromatin. 2018;11:37.","journal-title":"Epigenetics Chromatin"},{"key":"127_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-017-0672-1","volume":"16","author":"N M\u00e4kinen","year":"2017","unstructured":"M\u00e4kinen N, K\u00e4mpj\u00e4rvi K, Frizzell N, B\u00fctzow R, Vahteristo P. Characterization of MED12, HMGA2, and FH alterations reveals molecular variability in uterine smooth muscle tumors. Mol Cancer. 2017;16:1\u20138.","journal-title":"Mol Cancer"},{"key":"127_CR54","doi-asserted-by":"publisher","first-page":"320.e1","DOI":"10.1016\/j.ajog.2019.05.018","volume":"221","author":"A Mas","year":"2019","unstructured":"Mas A, Alonso R, Garrido-G\u00f3mez T, Escorcia P, Montero B, Jim\u00e9nez-Almaz\u00e1n J, et al. The differential diagnoses of uterine leiomyomas and leiomyosarcomas using DNA and RNA sequencing. Am J Obstet Gynecol. 2019;221:320.e1\u2013320.e23.","journal-title":"Am J Obstet Gynecol"},{"key":"127_CR55","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1097\/PAS.0000000000001572","volume":"45","author":"P Selenica","year":"2021","unstructured":"Selenica P, Conlon N, Gonzalez C, Frosina D, Jungbluth AA, Beets-Tan RGH, et al. Genomic profiling aids classification of diagnostically challenging uterine mesenchymal tumors with myomelanocytic differentiation. Am J Surg Pathol. 2021;45:77\u201392.","journal-title":"Am J Surg Pathol"},{"key":"127_CR56","doi-asserted-by":"publisher","unstructured":"Kolterud \u00c5, V\u00e4lim\u00e4ki N, Kuisma H, Patomo J, Ilves ST, M\u00e4kinen N, et al. Molecular subclass of uterine fibroids predicts tumor shrinkage in response to ulipristal acetate. Hum Mol Genet. 2022. https:\/\/doi.org\/10.1093\/hmg\/ddac217.","DOI":"10.1093\/hmg\/ddac217"},{"key":"127_CR57","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1097\/AOG.0000000000005475","volume":"143","author":"T Tamehisa","year":"2024","unstructured":"Tamehisa T, Sato S, Sakai T, Maekawa R, Tanabe M, Ito K, et al. Establishment of noninvasive prediction models for the diagnosis of uterine leiomyoma subtypes. Obstet Gynecol. 2024;143:358.","journal-title":"Obstet Gynecol"},{"key":"127_CR58","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/s41571-024-00869-z","volume":"21","author":"M Katoh","year":"2024","unstructured":"Katoh M, Loriot Y, Brandi G, Tavolari S, Wainberg ZA, Katoh M. FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions. Nat Rev Clin Oncol. 2024;21:312\u201329.","journal-title":"Nat Rev Clin Oncol"},{"key":"127_CR59","unstructured":"Center for Drug Evaluation, Research. FDA approves pemigatinib for relapsed or refractory myeloid\/lymphoid neoplasms with FGFR1 rearrangement. U.S. Food and Drug Administration. 2022. https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-approves-pemigatinib-relapsed-or-refractory-myeloidlymphoid-neoplasms-fgfr1-rearrangement. Accessed 14 Jun 2024."},{"key":"127_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.101204","volume":"4","author":"V Subbiah","year":"2023","unstructured":"Subbiah V, Verstovsek S. Clinical development and management of adverse events associated with FGFR inhibitors. Cell Rep Med. 2023;4:101204.","journal-title":"Cell Rep Med"}],"container-title":["BJC Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s44276-025-00127-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44276-025-00127-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44276-025-00127-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T13:05:13Z","timestamp":1740747913000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s44276-025-00127-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,27]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["127"],"URL":"https:\/\/doi.org\/10.1038\/s44276-025-00127-4","relation":{},"ISSN":["2731-9377"],"issn-type":[{"value":"2731-9377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,27]]},"assertion":[{"value":"4 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Ministry of Social Affairs and Health and the National Institute for Health and Welfare (53\/07\/2000, THL\/1071\/5.05.00\/2011, THL\/151\/5.05.00\/2017, THL\/1300\/5.05.00\/2019, THL\/1849\/14.6.00\/2024), the Ethics Committee of the Hospital District of Helsinki and Uusimaa (133\/E8\/03, 408\/13\/03\/03\/2009, 177\/13\/03\/03\/2016, HUS\/2509\/2016), the Swedish Ethical Review Authority (2022-02783-01), and the Swedish Ethical Committee (2016\/37-31\/1, and 2016\/2385-31\/4). The patient samples were collected with a written informed consent. This study was performed in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"9"}}